Biggest News Aggregation in the World
📰 Ioscience News

Page 9 - Ioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ioscience. Real-time updates on events, politics, business and more.

iTolerance, Inc. CEO to Present at the Bio LaunchPad Seminar at Georgia Tech's Institute for Bioengineering and Bioscience

Livestream presentation to be held on Thursday, March 30, 2023 at 11:00 AM ETMIAMI, FL / ACCESSWIRE / March 29, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine
United States Jenene Thomas Susan Roberts Anthony Japour Tolerance Inc University Of Louisville

Satellos Bioscience Inc.: Satellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible Debentures

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics
United States Christina Cameron Ryan Mitchell Michael Rudnicki Geoff Mackay Frank Gleeson

Satellos Bioscience Inc.: Satellos Bioscience to Present at Annual MDA Clinical and Scientific Conference and Insights in Research Investor Summit

Ryan Mitchell, PhD and Director of Business Development at Satellos to highlight SAT-3153 and Satellos' novel muscle regeneration technology in two forums at this year's MDA Conference and Summit Toronto
United States Dennis Riedl Christina Cameron Ryan Mitchell Phil Lambert Michael Rudnicki

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Skye Bioscience, Inc.: Skye Bioscience Receives Human Research Ethics Committee Approval to Start Multiple Ascending Dose Arm of Phase 1 Study of SBI-100 Ophthalmic Emulsion

San Diego, California--(Newsfile Corp. - March 15, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative
San Diego United States United Kingdom Dennis Riedl Skye Bioscience Punit Dhillon

Satellos Bioscience Inc.: Satellos Bioscience Announces Proposed Non-Brokered Offering of Unsecured Non-Convertible Debentures of up to $2.25 Million

Toronto, Ontario--(Newsfile Corp. - March 15, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics
United States Dennis Riedl Christina Cameron Ryan Mitchell Geoff Mackay Michael Rudnicki

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science